Search Results - "Elsharoud, Amro"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model by Park, Hang-soo, Chugh, Rishi Man, El Andaloussi, Abdeljabar, Hobeika, Elie, Esfandyari, Sahar, Elsharoud, Amro, Ulin, Mara, Garcia, Natalia, Bilal, Mahmood, Al-Hendy, Ayman

    Published in Scientific reports (25-02-2021)
    “…Primary ovarian insufficiency (POI) is defined as the loss of ovarian function before 40 years of age. It clinically manifests as amenorrhea, infertility, and…”
    Get full text
    Journal Article
  2. 2

    Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model by Park, Hang-Soo, Chugh, Rishi Man, Elsharoud, Amro, Ulin, Mara, Esfandyari, Sahar, Aboalsoud, Alshimaa, Bakir, Lale, Al-Hendy, Ayman

    Published in Cell transplantation (2021)
    “…Primary ovarian insufficiency (POI), a condition in which there is a loss of ovarian function before the age of 40 years, leads to amenorrhea and infertility…”
    Get full text
    Journal Article
  3. 3

    Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2 by Chugh, Rishi Man, Park, Hang-soo, Esfandyari, Sahar, Elsharoud, Amro, Ulin, Mara, Al-Hendy, Ayman

    “…Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. Previous studies have demonstrated the therapeutic efficacy of human bone…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency by Mohamed, Sara A, Shalaby, Shahinaz, Brakta, Soumia, Elam, Lelyand, Elsharoud, Amro, Al-Hendy, Ayman

    Published in Biomedicines (18-01-2019)
    “…Premature ovarian insufficiency (POI) is a challenging disease, with limited treatment options at the moment. Umbilical cord blood mesenchymal stem cells…”
    Get full text
    Journal Article
  8. 8

    A presentation of ovarian fibrothecoma in a middle-aged female with recurrent massive ascites and postmenopausal bleeding: A case report by Elsharoud, Amro, Brakta, Soumia, Elhusseini, Heba, Al-Hendy, Ayman

    Published in SAGE open medical case reports (2020)
    “…Fibrothecomas are mostly benign ovarian tumors. We describe a rare case of fibrothecoma in a 59-year-old woman with a history of recurrent massive ascites and…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    What We Know about the Long-Term Risks of Hysterectomy for Benign Indication—A Systematic Review by Madueke-Laveaux, Obianuju Sandra, Elsharoud, Amro, Al-Hendy, Ayman

    Published in Journal of clinical medicine (16-11-2021)
    “…Hysterectomy is the most common treatment option in women with uterine fibroids, providing definitive relief from the associated burdensome symptoms. As with…”
    Get full text
    Journal Article
  13. 13
  14. 14